GKOS Logo

Glaukos Corporation (GKOS) 

NYSE
Market Cap
$7.7B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
679 of 963
Rank in Industry
81 of 120

Largest Insider Buys in Sector

GKOS Stock Price History Chart

GKOS Stock Performance

About Glaukos Corporation

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Insider Activity of Glaukos Corporation

Over the last 12 months, insiders at Glaukos Corporation have bought $0 and sold $61.86M worth of Glaukos Corporation stock.

On average, over the past 5 years, insiders at Glaukos Corporation have bought $0 and sold $20.27M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,200 shares for transaction amount of $100,128 was made by Gilliam Joseph E () on 2017‑11‑22.

List of Insider Buy and Sell Transactions, Glaukos Corporation

2024-10-30SalePRESIDENT & COO
2,275
0.0041%
$138.97$316,157+1.30%
2024-09-09Saledirector
3,000
0.0055%
$130.67$392,000+2.28%
2024-08-21SalePRESIDENT & COO
5,000
0.0091%
$129.36$646,791+1.93%
2024-08-15Saledirector
6,250
0.0118%
$125.93$787,0860.00%
2024-08-08Saledirector
25,000
0.0453%
$120.00$3M+9.39%
2024-07-05SalePRESIDENT & COO
2,250
0.0046%
$121.39$273,1280.00%
2024-06-03SalePRESIDENT & COO
2,500
0.0049%
$113.50$283,751+12.27%
2024-05-30Saledirector
5,000
0.01%
$112.00$560,000+15.75%
2024-05-15Saledirector
6,250
0.0126%
$112.80$704,993+14.59%
2024-05-10SalePRESIDENT & COO
2,395
0.0048%
$110.56$264,791+14.84%
2024-05-10SaleSVP & CHIEF FINANCIAL OFFICER
316
0.0006%
$110.43$34,896+14.84%
2024-05-10SaleSVP & CHIEF FINANCIAL OFFICER
353
0.0007%
$110.51$39,011+14.84%
2024-05-06SalePRESIDENT & COO
105
0.0002%
$110.36$11,588+20.49%
2024-05-06SaleSVP & CHIEF FINANCIAL OFFICER
90
0.0002%
$110.26$9,923+20.49%
2024-05-02SalePRESIDENT & COO
2,059
0.0041%
$105.52$217,263+20.29%
2024-05-02SaleSVP & CHIEF FINANCIAL OFFICER
442
0.0009%
$105.69$46,713+20.29%
2024-04-08SalePRESIDENT & COO
59,801
0.1207%
$100.47$6.01M+21.77%
2024-04-08SaleSVP & CHIEF FINANCIAL OFFICER
1,372
0.0028%
$100.54$137,944+21.77%
2024-04-05SalePRESIDENT & COO
2,457
0.005%
$96.81$237,862+26.39%
2024-04-05SaleSVP & CHIEF FINANCIAL OFFICER
262
0.0005%
$96.63$25,316+26.39%

Insider Historical Profitability

40.06%
Gilliam Joseph EPRESIDENT & COO
102169
0.1853%
$139.66139+49.43%
Burns Thomas WilliamCHAIRMAN & CEO
55835
0.1013%
$139.66145+18.1%
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
51647
0.0937%
$139.66014
Stapley Marcdirector
34076
0.0618%
$139.6604
Foley Mark Jdirector
33220
0.0602%
$139.6601
Kliman Gilbert Hdirector
32336
0.0586%
$139.6609
WEISNER AIMEE Sdirector
30119
0.0546%
$139.6621+57.32%
MONTREUX EQUITY PARTNERS IV LP10 percent owner
3209812
5.8215%
$139.6601
Calcaterra Chris M.Chief Operating Officer
163806
0.2971%
$139.66015
VERSANT VENTURES I LLC
51247
0.0929%
$139.6601
LINK WILLIAM J PHDdirector
15439
0.028%
$139.6605
MORE ROBERT Jdirector
5000
0.0091%
$139.6610
HARRISON RICHARD L
1388
0.0025%
$139.6618+18.1%
ORBIMED ADVISORS LLCdirector
0
0%
$139.66017
SILVERSTEIN JONATHANdirector
0
0%
$139.66017

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$744.61M15.687.9M+0.03%+$255,997.350.02
Fidelity Investments$693.68M14.617.36M+26.43%+$145M0.05
The Vanguard Group$500.58M10.545.31M+1.38%+$6.8M0.01
Brown Capital Management$201.11M4.242.13M-20.94%-$53.27M3.57
State Street$172.15M3.631.83M+0.48%+$829,657.710.01
Janus Henderson$151.89M3.21.61M-0.35%-$532,353.510.08
Invesco$151.26M3.191.6M+2.01%+$2.97M0.03
Lord Abbett$142.75M3.011.51M+213.55%+$97.22M0.5
Ameriprise Financial$137.61M2.91.46M+28.4%+$30.43M0.04
Millennium Management LLC$125.15M2.641.33M+29.7%+$28.66M0.08
Alger$116.11M2.451.23M-25.15%-$39M0.58
Artisan Partners$115.31M2.431.22M0%+$00.17
Geode Capital Management$97.88M2.061.04M+2.97%+$2.82M0.01
Dimensional Fund Advisors$86.57M1.82918,156-0.58%-$506,337.300.02
PRIMECAP Management Co$80.02M1.69848,635+7.42%+$5.53M0.06
Driehaus Capital Management LLC$61.1M1.29647,997+10.04%+$5.58M0.61
Morgan Stanley$51.96M1.09551,024-16.8%-$10.49M<0.01
Capital World Investors$51.89M1.09550,3220%+$00.01
Riverbridge Partners$50.4M1.06534,514-2.48%-$1.28M0.62
Northern Trust$50.24M1.06532,817-1.82%-$932,622.410.01
New York State Common Retirement Fund$48.53M1.02514,730+0.33%+$160,387.650.07
Braidwell Lp$42.49M0.9450,676+85.65%+$19.6M2.41
Iron Triangle Partners LP$40.5M0.85429,525+75.6%+$17.44M4.31
Loomis, Sayles & Company$40.05M0.84424,724-2.64%-$1.09M0.06
American Century Investments$39.94M0.84423,566-0.15%-$58,648.380.03
Wellington Management Company$39.82M0.84422,282-68.5%-$86.58M0.01
Charles Schwab$38.43M0.81407,535+3.9%+$1.44M0.01
Gilder Gagnon Howe & Co. LLC$38.03M0.8403,308+361.13%+$29.78M0.49
BNY Mellon$36.51M0.77387,170-5.71%-$2.21M0.01
Nuveen$31.99M0.67339,361-8.44%-$2.95M0.01
Bank of America$27.34M0.58290,000-21.91%-$7.67M<0.01
Goldman Sachs$21.73M0.46230,420+81.95%+$9.79M<0.01
Avidity Partners Management Lp$21.12M0.45224,000New+$21.12M0.8
Adage Capital Partners Gp L L C$18.86M0.4200,0000%+$00.03
Royal Bank of Canada$18.65M0.39197,810-21.62%-$5.14M<0.01
C Worldwide Group Holding A S$18.59M0.39197,2120%+$00.21
Nomura Holdings$18.29M0.39193,994-16.39%-$3.59M0.16
Atika Capital Management Llc$16.5M0.35175,000+40.04%+$4.72M1.97
Allspring Global Investments$15.66M0.33166,054+127.54%+$8.78M0.03
Renaissance Technologies$14.9M0.31157,992-4.65%-$726,029.800.02
KeyBank$13.42M0.28142,358-0.06%-$7,920.360.05
Legal & General$13.21M0.28140,104+4.27%+$541,130.26<0.01
RhumbLine Advisers$12.82M0.27136,012-1.49%-$193,388.290.01
Polar Asset Management Partners Inc$10.95M0.23116,136+274.2%+$8.02M0.22
Man Group Plc$10.81M0.23114,696-45.83%-$9.15M0.03
Cubist Systematic Strategies$10.63M0.22112,718-40.52%-$7.24M0.09
Segall Bryant & Hamill$10.12M0.21107,282+20.82%+$1.74M0.19
Connor Clark & Lunn Investment Management Ltd$9.52M0.2100,936+3.21%+$295,787.720.02
Public Sector Pension Investment Board$9.43M0.2100,032-1.06%-$100,890.300.07
PEREGRINE CAPITAL MANAGEMENT INC$9.25M0.298,140-0.96%-$89,669.790.27
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.